Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Algernon Pharmaceuticals Inc. C.AGN

Alternate Symbol(s):  AGNPF

Algernon Pharmaceuticals Inc. is a clinical-stage drug development company. The Company is focused on developing repurposed therapeutic drugs in the areas of non-alcoholic steatohepatitis (NASH), a type of liver disease, chronic kidney disease (CKD), inflammatory bowel disease (IBD), idiopathic pulmonary fibrosis (IPF) and chronic cough as well as advancing a stroke program using N, N-Dimethyltryptamine (DMT). The Company operates through two segments, which includes the development of repurposed therapeutic drugs in Canada and the facilitation of the Company’s lead drug candidates into off-label phase II clinical trials (humans) in Australia. The Company's pipeline includes NP-251 (Repirinast) and AP-188 (DMT). The Company, through its subsidiary, Algernon NeuroScience Inc., is developing AP-188 (DMT) as a potential treatment for stroke and traumatic brain injury (TBI) recovery. Its NP-251 is being developed as a potential treatment for kidney inflammation and fibrosis.


CSE:AGN - Post by User

Post by C10H12N2on Dec 30, 2022 1:30am
403 Views
Post# 35196525

You're FN Crazy!

You're FN Crazy!

Stop me when you think any of this is false or inaccurate:


Christopher Temple 

Self proclaimed neo-Nazi


Self proclaimed White Nationalist


Marched with neo-Nazi's


Quotes Hitler


Spoken at Aryan Nation gatherings


Written for or edited anti-Semitic publications


Worked for former Klan leader David Duke


Worked for Holocaust denier Willis Carto


Former friend of Louis Beam, a firmer Texas Klan member once in the FBI's Ten Most Wanted List


On Sept. 17, a federal grand jury in Wisconsin indicted Christopher L. Temple on 67 counts of mail fraud and money laundering — charges that could bring him a maximum of 1,340 years in prison and perhaps $20 million in fines. Temple is charged with stealing $1.6 million from his clients.


Temple was already reading The Spotlight, a poorly produced tabloid that contained a bizarre mix of anti-Semitism, Holocaust denial, conspiracy theories, dubious medical advice and products, and a heavy dose of extreme-right economic theories, with their customary emphasis on gold.


He co-founded the United Citizens for Justice, a radical group formed as a result of a standoff between white supremacist Randy Weaver and the federal government.


He often focused on gold — with its special appeal to radical rightists who believe that only gold, unlike money, has intrinsic value — but he did not only promote its purchase. Often, he suggested selling.


Ultimately, investigators determined Temple had allegedly swindled $1.6 million from investors between 1998 and 2003. The investors thought they had invested in funds that, on paper, were bringing in remarkable profits — some 24.9% in the six months.


Instead of investing that money, the indictment charges, Temple used it to pay for living expenses, publishing, and buying and remodeling his home. He also allegedly used some of it to pay off earlier investors in a classic Ponzi scheme.


Machon says he tracked Temple's stock picks for four years while working as a firefighter. The returns were so good that Machon ultimately took $12,000 from his retirement account to invest. When he asked for it back, Machon alleges, Temple demurred. "He's smart," Machon told the Report, "but he's just a crook."


sentenced to six years in federal prison for ripping off investors he promised to make rich. He pleaded guilty in July to one count each of mail fraud and money laundering.


Full stop


Umm... Algernon Pharmaceuticals (a publicly traded company) made a leadership decision to post ^THAT GUY OF ALL GUYS^ investment opinion to its corporate website.


Do you believe that type of decision does not warrant an explanation from the company? Like, it's just OK to go around quoting and endorsing someone with a track record like ^THAT GUY"? 


It's an insane proposition to think at minimum Americans would put up with that type of incompetence coming out of Algernon Pharmaceuticals. My best guess is Wall Street surely  vetted the leadership of Algernon Pharmaceuticals Inc and took a pass.


One colossal blunder after the next and you morons remain silent and weak. Pathetically chasing after lost profits while Algernon is fire selling the company out from under American investors.


Since the 100/1 reverse split you will go from 1.6M outstanding to 5M outstanding. That's about 220% dilution of shares when all is said and done with this go around in financing. They will come back to the Cads for at least another 5M sale raise that you will also be shut out of as Americans. 


Land Of The Free And The Home Of The Brave. Yeah, ok


Yeah, I get it. You want to recoup epic losses but you're willing to stoop just as low as Algernon Pharmaceuticals who continues to drag you down a hellhole for how much profit...when? The pearly gates I know of will judge us all one day. I'm of the belief there will be a box checked off in this instance at Algernon Pharmaceuticals for all investors big and small. You're either part of the solution or part of the problem as you head further and further down into Dante's Inferno better known as Algernon Pharmaceuticals Inc.


Your leadership continues to fail you. This latest Book of Revelations is way up there on the list of lack of decency. Your leaders either failed to vet Christopher Temple before posting his investment "opinion" or they know exactly who he is which begs the question of who exactly are the leaders of Algernon Pharmaceuticals? How much of Christopher Temple's overall life experiences do they know about and  personally/professionally align with? 


An even bigger question is what do they think about you, the individual investor and your intelligence and willingness to take it up the rear end at all cost? 


From what I can tell your collective rectums have no intolerable limit.


Yeah, I'm not supposed to call out any of these sordid actions?


YOU'RE FN CRAZY!




<< Previous
Bullboard Posts
Next >>